Program:

8.30-9.00 Arrival, registration
 

9.00 Welcome by organisers (RH)
 

9.10-10.40 Session 1 – ECRs [Chair: Renee van der Sluis]

• Audrey Andersen-Civil (DANDRITE): “Investigating the impact of chemically induced neurodevelopmental disorders on gut immunity”
• Line Reinert (Biomedicine): “Distinct roles for immunological DNA and RNA sensing path-ways in control of genital HSV-2 replication and restriction of neuroinvasion”
• Arlette Alina Haidar Montes (iNANO): “Chemically Enhanced RNA Aptamers as a Tar-geted Drug Delivery Platform for Vitiligo Immunotherapy”
• Christina Espeseth Grand (Clinical Medicine): “Your Blood Knows: Immune Receptor Repertoires Predict Outcomes in Localized RCC”
• Emil Aagaard Thomsen (Biomedicine): “A comprehensive map of the genetic network regulating type 1 interferon expression through the cGAS-STING Pathway”
• Emilio Sopprani (Molecular Biology & Genetics): “Astrocyte neuroimmune reprogram-ming in OGT-associated intellectual disability”

10.40-11.00 Coffee break

11.00-12.30 Session 2 – ECRs [Chair: Martin Tolstrup]

• Giacomo Schmidt Frattari (Clinical Medicine): “CD4⁺ T Cell Immune Activation Capacity Prior to Treatment Interruption Distinguishes Post-Intervention Controllers of HIV”
• Josephine Baunvig Aagaard (Biological and Chemical Engineering): “Dissection and in-hibition of insect venom-mediated anaphylaxis by nanobody-based mono- and bi-specific antibody formats”
• Julie Weber: “Effects of Trichuris muris Infection on Bone Marrow Hematopoiesis and Innate Immune Function”
• Aneta Jurkiewicz (Molecular Biology & Genetics): “Molecular mechanisms of STING-me-diated NF-κB signalling in humans”
• Anna Hvarregaard Christensen (Molecular Biology & Genetics): “STING-mediated NF-kB activation in Drosophila melanogaster”
• Baocun Zhang (Biomedicine): “TBD”

12.30-13.30 Lunch

13.30-15.00 Session 3 – ECRs [Chair: Lilian Kisiswa]

• Leandro Silva Da Costa (Biomedicine): “Dual effects of Vesicular Stomatitis Virus variants on NLRP1 activation reveal divergent host–virus interactions”
• Maria Elisabeth Harder (Biomedicine): “On-Treatment Immune Dynamics Serve as Early Predictors of Immunotherapy Outcomes for Patients with Metastatic Melanoma”
• Marvin Werner (Biomedicine): “Non-canonical deficiency of IRF8 impairs STING signal-ing and underlies recurrent HSV-2 meningitis”
• Nathalie Jäck (Biomedicine): “An in vitro system for testing human antibody responses to carbohydrate antigens”
• Thomas Emmanuel (Aarhus University Hospital): “Transcriptomic Profiling of Darier Dis-ease via Bulk RNA-Seq”
• Thomas Gravgaard Andersen (Biomedicine): “Transcription Factor-mediated Revitaliza-tion of Tumor-Infiltrating Exhausted T cells for Improved Cancer Therapy”

15.00-15.30 Coffee break

15.30-16.30 Session 4 – PIs [Chair: David Olagnier]

• Søren Degn (Biomedicine): “T-bet-dependent B cells can orchestrate CD8 T cell activa-tion”
• Christian Holm (Biomedicine): “Potential of KEAP1-inhibtion to Reverse Goblet Cell Hy-perplasia”
• Thomas Kim (DANDRITE): “Metabolic Checkpoints Governing Microglial Innate Immune Responses in Neurodegeneration”

16.30-17.00 Concluding remarks (RH/SRP)

17.00 End